Merck potential purchase of Seagen said unlikely by earnings date - report

Jul. 15, 2022 6:01 PM ETSeagen Inc. (SGEN), MRKDSKYFBy: Joshua Fineman, SA News Editor5 Comments

Merck & Co. headquarters in Silicon Valley

Sundry Photography

Merck's (NYSE:MRK) potential $40 billion acquisition of Seagen (NASDAQ:SGEN) is not likely to happen ahead of the pharma co.'s earnings later this month, though talks still remain on track.

The WSJ reported earlier this month that Merck (

Recommended For You

Comments (5)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.